159 results on '"Saw, Robyn P. M."'
Search Results
2. Uncovering the complex relationship between balding, testosterone and skin cancers in men
3. Study protocol for a randomised controlled trial to evaluate the use of melanoma surveillance photography to the Improve early detection of MelanomA in ultra-hiGh and high-risk patiEnts (the IMAGE trial)
4. Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
5. The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
6. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
7. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
8. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
9. Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework
10. Histological regression in melanoma: impact on sentinel lymph node status and survival
11. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
12. Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction
13. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
14. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
15. Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
16. Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center
17. Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival
18. A systematic review with evidence mapping of supportive care interventions for melanoma patients and caregivers
19. Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
20. Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
21. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
22. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination
23. Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
24. Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome
25. Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma
26. Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
27. Additional file 1 of Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework
28. Additional file 1 of Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
29. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study.
30. Abstract 2761: CODEX highly multiplex image mapping to CITEseq datasets reveal the spatial dynamics of the TME during the development of acquired resistant in immunotherapy treated melanoma
31. Additional file 4 of Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
32. Additional file 1 of Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
33. Additional file 3 of Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
34. Additional file 2 of Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
35. Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
36. Whole-genome landscapes of major melanoma subtypes
37. Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
38. Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
39. Treatment of in-transit Merkel cell carcinoma by isolated limb infusion with cytotoxic drugs.
40. Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications
41. Multiplex melanoma families are enriched for polygenic risk.
42. Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management.
43. Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study.
44. Pigmented lesions of the nail bed - Clinical assessment and biopsy.
45. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).
46. Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma.
47. Diverse presentations of acral melanoma.
48. Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy.
49. Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.
50. Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.